Metabolism-based cardiomyocytes production for regenerative therapy

Area of Science:

• Stem Cell Biology
• Metabolic Regulation
• Cardiovascular Research

Background:

• Human pluripotent stem cells (hPSCs) are vital for cardiac regenerative therapy, disease modeling, and drug screening.
• hPSC-derived cardiomyocytes (hPSC-CMs) offer an alternative to heart transplantation.
• hPSCs exhibit distinct metabolic programs crucial for maintaining pluripotency.

Purpose of the Study:

• To review the metabolic programs inherent in hPSCs.
• To explore the role of metabolic regulation in the production of hPSC-CMs for cardiac applications.
• To connect metabolic understanding with advancements in cardiac regenerative therapy.

Main Methods:

• Literature review of metabolic programs in hPSCs.
• Analysis of metabolic regulation during hPSC-CM differentiation and maturation.
• Synthesis of findings related to clinical applications in cardiac repair.

Main Results:

• hPSCs possess unique metabolic pathways essential for pluripotency maintenance.
• Metabolic regulation is critical throughout the stepwise specification of hPSC-CMs.
• Metabolic insights inform strategies for mesoderm induction, cardiac progenitor specification, and cardiomyocyte maturation.

Conclusions:

• Understanding hPSC metabolism is key to optimizing hPSC-CM production for cardiac regenerative therapy.
• Metabolic regulation strategies can enhance the efficiency and efficacy of hPSC-CMs for clinical use.
• This review highlights the translational potential of metabolic research in cardiovascular stem cell therapy.